Editorial - Journal of Cell Biology and Metabolism (2018) Histology and Cell Biology
Stem cell therapy.
- *Corresponding Author:
- Ibrahim KI
Department of Histology and Cell Biology
Tel: +20 102 722 7142
E-mail: [email protected]
Accepted Date: November 15, 2017
Citation: Ibrahim KI. Stem cell therapy. J Child Adolesc Health. 2018;1(1):1-2.
What are stem cells? Stem cells are no differentiated cells that have the ability of proliferation, regeneration, conversion to differentiated cells and tissue production. Regeneration means that these cells have the ability of asymmetric division which one of the resulting cells remains as stem cell while another cell, which is called daughter cell, becomes one cell of germ layer. Stem cells may remain inactive for a long time till they enter cell division again
What are stem cells? Stem cells are no differentiated cells that have the ability of proliferation, regeneration, conversion to differentiated cells and tissue production. Regeneration means that these cells have the ability of asymmetric division which one of the resulting cells remains as stem cell while another cell, which is called daughter cell, becomes one cell of germ layer. Stem cells may remain inactive for a long time till they enter cell division again [1,2].
For the first time in 1981, researchers could isolate stem cells from mouse embryos. More accurate studies on the biology of mouse stem cells led to discovery of methods for separation of stem cells from the human embryo in 1998 [3-5]. Stem cells are divided into two groups: embryonic and adult stem cells. Embryonic stem cells are derived from zygote cell which is fertilized in vitro and usually is 4-5-day embryo that is in the form of a hollow ball called blastocyst. Blastocyst is composed of three parts: the trophoblast layer that is surrounding blastocyst, a hollow cavity inside the blastocyst and inner cell mass that changes to embryo. Since zygote cells can differentiate into placenta and fetal cells, sometimes they are considered as the only true totipotent stem cells. Because the inner cell mass of the blastocyst does not have the ability to differentiate into placenta cells, it is called the pluripotent cell. Non-differentiated cells other than embryonic stem cells can be found in differentiated cells of specific tissues after birth. These cells are called adult or non-embryonic stem cells but more accurate word for them is "somatic stem cells" because these cells also exist in children and umbilical cord. They are divided into two main categories: hematopoietic stem cells that can differentiate into blood cells and mesenchymal stem cells that are less differentiated. Nose, muscle, liver, skin, brain, retina and limbus of the eye are the other sources of adult stem cells. One of the most important advantages of adult stem cells over embryonic stem cells is because of the fact that they can be obtained without the need for destruction of embryo [6,7].
The pluripotent stem cell differentiates into the multipotent cell of 3 different germ layers (ectoderm, mesoderm and endoderm layer). The multipotent cell differentiates into unipotent cell of a specific cell lineage within its germ layer . If differentiation process is successful, the resulting cells will be called as progenitor cells or stem cell-like cells that have the capability of regeneration . Stem cell therapy has been evaluated in various blood diseases (such as lymphoblastic leukemia, myeloid leukemia, thalassemia, multiple myeloma, cell cycle anemia).
Stem cell therapy has been also evaluated in treatment of Parkinson's disease , Amyotrophic lateral sclerosis , Alzheimer , Stroke , Spinal Cord Injury , Multiple Sclerosis , Radiation Induced Intestinal Injury , Inflammatory Bowel Disease , Liver Disease , Duchenne Muscular Dystrophy , Diabetes , Heart Disease , Bone Disease , Renal Disease , Chronic Wounds , Graft-Versus-Host Disease , Sepsis  and Respiratory diseases .
- Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development. 1990;110(4):1001-20.
- Orford KW, Scadden DT. Deconstructing stem cell selfrenewal: genetic insights into cell-cycle regulation. Nat Rev Genet. 2008;9(2):115-28.
- Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292(5819):154-6.
- Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA. 1981;78(12):7634-8.
- Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145-7.
- National Institutes of Health (NIH) Stem Cell Information Home Page. In: Stem Cell Information [Internet]. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Services, 2011 [cited 2012 Feb 17]; Available from: http://stemcells.nih.gov/index
- Tuch BE. Stem cells: a clinical update. Aust Fam Physician. 2006;35(9):719-21.
- Nandoe Tewarie RS, Hurtado A, Bartels RH, et al. Stem cell-based therapies for spinal cord injury. J Spinal Cord Med. 2009;32(2):105-14.
- Venkataramana NK, Kumar SK, Balaraju S, et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl Res. 2010;155(2):62-70.
- Appel SH, Engelhardt JI, Henkel JS, et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 2008;71(17):1326-34.
- Lee HJ, Lee JK, Lee H, et al. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci Lett 2010;481(1):30-5.
- Stroemer P, Hope A, Patel S, et al. Development of a human neural stem cell line for use in recovery from disability after stroke. Front Biosci 2008;13:2290-2.
- Kerr CL, Letzen BS, Hill CM, et al. Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int J Neurosci 2010;120(4):305-13.
- Barhum Y, Gai-Castro S, Bahat-Stromza M, et al. Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J Mol Neurosci 2010;41(1):129-37.
- Zhang J, Gong JF, Zhang W, et al. Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice. J Biomed Sci 2008;15(5):585-94.
- González MA, Gonzalez-Rey E, Rico L, et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009;136(3):978-89.
- Soto-Gutierrez A, Navarro-Alvarez N, Yagi H, et al. Stem cells for liver repopulation. Curr Opin Organ Transplant 2009;14(6):667-73.
- Cossu G, Sampaolesi M. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol Med 2007;13(12):520-6.
- Hori Y. Insulin-producing cells derived from stem/progenitor cells: therapeutic implications for diabetes mellitus. Med Mol Morphol 2009;42(4):195-200.
- Martin-Rendon E, Brunskill SJ, Hyde CJ, et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008;29(15):1807-18.
- Tseng SS, Lee MA, Reddi AH. Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am 2008;90 Suppl 1:92-8.
- Iwatani H, Imai E. Kidney repair using stem cells: myth or reality as a therapeutic option? J Nephrol 2010;23(2):143-6.
- Cha J, Falanga V. Stem cells in cutaneous wound healing. Clin Dermatol. 2007;25(1):73-8.
- Toubai T, Paczesny S, Shono Y, et al. Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation. Curr Stem Cell Res Ther. 2009;4(4):252-9.
- Weil BR, Markel TA, Herrmann JL, et al. Stem cells in sepsis. Ann Surg. 2009;250(1):19-27.
- Zhen G, Liu H, Gu N, et al. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci. 2008;13:3415-22.